deoxyglucose has been researched along with Carcinoma, Hepatocellular in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (22.92) | 18.7374 |
1990's | 15 (31.25) | 18.2507 |
2000's | 10 (20.83) | 29.6817 |
2010's | 10 (20.83) | 24.3611 |
2020's | 2 (4.17) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Dong, QZ; Gao, S; Hu, BY; Jia, HL; Li, TE; Lin, ZF; Lu, L; Pan, JJ; Qin, LX; Wang, X; Wu, C; Xu, D; Zhang, Z; Zheng, Y; Zhu, Y | 1 |
Egashira, K; Fukuda, K; Hara, Y; Hino, K; Nishina, S; Sasaki, K; Yamamura, M; Yamauchi, A | 1 |
Cai, H; Cao, K; Chen, Z; Li, W; Liu, X; Wang, J; Wu, L; Zhao, J | 1 |
Alves, AP; Alves, MG; Botelho, MF; Maia, CJ; Mamede, AC; Oliveira, PF; Rocha, SM | 1 |
Dai, C; Su, R; Tian, X; Zhang, R; Zhang, Y | 1 |
Cheng, G; Dilip, A; Gamblin, TC; Joseph, J; Kalyanaraman, B; Kunnimalaiyaan, M; Kunnimalaiyaan, S | 1 |
Artlett, CM; Loarca, L; Sassi-Gaha, S | 1 |
Chow, EK; Ho, CM; Ho, D; Mohd Abdul Rashid, MB; Nurrul Abdullah, L; Silva, A; Toh, TB | 1 |
Chen, J; Dai, Y; Jia, L; Jiang, Z; Li, Y; Lin, L; Lu, Y; Ou, M; Shao, J; Wang, J; Xiang, L; Yang, X | 1 |
Ghoshal, K; Jacob, ST; Motiwala, T; Reyes, R; Wani, NA | 1 |
Ellinger, A; Meisslitzer-Ruppitsch, C; Neumüller, J; Pavelka, M; Ranftler, C | 1 |
Aszalos, A; Finkel, T; Gottesman, MM; Liang, XJ; Shen, DW; Yin, JJ | 1 |
Kuang, Y; Lee, Z; Maclennan, GT; Salem, N; Wang, F | 1 |
Che, XF; Miyazawa, K; Moriya, S; Tabuchi, T; Takemura, A; Tomoda, A | 1 |
GOERLICH, M; HEISE, E; KEMSIES, C | 1 |
ELZINA, NV | 1 |
Friedlander, G; Laouari, D; Ledoux, S; Yang, R | 1 |
Ardehali, H; Beechem, JM; Granner, DK; Perriott, LM; Powers, AC; Van der Meer, W; Whitesell, RR | 1 |
Chen, X; Li, J; Liu, W; Qi, D; Qiao, L; Wang, A; Wei, K; Wu, J; Xue, Q | 1 |
Gao, MT; Kou, W; Qiao, L; Wang, AQ; Wu, J; Xue, QJ; Zhou, YN | 1 |
Aoki, K; Kaburagi, Y; Saito, T; Satoh, S; Sekihara, H; Yamashita, R | 1 |
Fukuda, H; Furumoto, S; Ishioka, C; Iwata, R; Suzuki, M; Yamaguchi, K; Yamaura, G; Yoshioka, T | 1 |
Chan, CM; Chan, YW; Che, CT; Fung, KP; Ho, YY; Lam, FC; Lau, CB; Lau, CH; Lau, KM; Lau, TW; Leung, PC | 1 |
Kurtoglu, M; Lampidis, TJ; Maher, JC; Savaraj, N; Wangpaichitr, M | 1 |
Inokuma, T; Konishi, J; Magata, Y; Sasayama, S; Tamaki, N; Tanaka, A; Torizuka, T; Yamamoto, K; Yamaoka, Y; Yonekura, Y | 1 |
Hall, K; Isaksson, M; Lindgren, BF; Stern, I | 1 |
Hosokawa, C; Ikeda, H; Kamino, T; Kawabe, J; Ochi, H; Okamura, T; Onoyama, Y | 1 |
Inokuma, T; Konishi, J; Magata, Y; Tamaki, N; Tanaka, A; Torizuka, T; Yamamoto, K; Yamaoka, Y; Yonekura, Y | 1 |
Alpert, NM; Fischman, AJ; Goldberg, MA; Lee, MJ; Mueller, PR; Thrall, JH | 1 |
Ashwell, G; Morell, AG; Stockert, RJ; Weiss, P | 1 |
Dimitrakopoulou-Strauss, A; Doll, J; Gutzler, F; Irngartinger, G; Oberdorfer, F; Strauss, LG; Stremmel, W; van Kaick, G | 1 |
Abdullah, N; Fantus, IG; Tsiani, E | 1 |
Erbe, J; Plagemenn, PG; Richey, DP; Zylka, JM | 1 |
Plagemann, PG; Sheppard, JR | 1 |
Graff, JC; Marz, R; Plagemann, PG; Wohlhueter, RM | 1 |
Liu, CK; Schmied, R; Waxman, S | 1 |
Asano, T; Enomoto, K; Hayashi, H; Isono, K; Kikuchi, T; Okazumi, S; Ozaki, M; Ryu, M; Yamamoto, H | 1 |
Eremin, O; Evans, NT; Gvozdanovic, D; Heys, SD; Mallard, JR; Roeda, D; Smith, FW | 1 |
Haney, PM; James, DE; Mueckler, M; Piper, RC; Slot, JW | 1 |
Asano, T; Enomoto, K; Fukunaga, T; Imazeki, K; Isono, K; Itoh, H; Kikuchi, T; Nagashima, T; Okazumi, S; Yamamoto, H | 1 |
Fukuda, H | 1 |
Buxton, JM; Carruthers, A; Chlapowski, FJ; Czech, MP; Harrison, SA; Helgerson, AL; MacDonald, RG | 1 |
Buxton, JM; Clancy, BM; Czech, MP; Harrison, SA | 1 |
Keller, K; Mueckler, M; Strube, M | 1 |
Cornelius, P; Lee, MD; Marlowe, M; Pekala, PH | 1 |
Kaback, HR; Lodish, HF; Sarkar, HK; Thorens, B | 1 |
Ahonen, A; Nordman, E; Paul, R; Roeda, D | 1 |
Erbe, J; Plagemann, PG | 1 |
2 review(s) available for deoxyglucose and Carcinoma, Hepatocellular
Article | Year |
---|---|
Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?
Topics: Antimetabolites; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Deoxyglucose; Flavonoids; Glucose Transporter Type 1; Glycolysis; Humans; Imatinib Mesylate; Liver Neoplasms; Protein Kinase Inhibitors | 2019 |
Inhibition of carrier-mediated and non-mediated permeation processes by cytochalasin B.
Topics: Animals; Biological Transport; Biological Transport, Active; Blood Glucose; Carcinoma, Hepatocellular; Cytochalasin B; Cytochalasins; Deoxyglucose; Erythrocytes; Hexoses; Humans; Kinetics; Liver Neoplasms; Methylglucosides; Neoplasms, Experimental; Rats; Thermodynamics | 1978 |
1 trial(s) available for deoxyglucose and Carcinoma, Hepatocellular
Article | Year |
---|---|
Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Necrosis; Tomography, Emission-Computed | 1994 |
45 other study(ies) available for deoxyglucose and Carcinoma, Hepatocellular
Article | Year |
---|---|
MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming.
Topics: Carcinoma, Hepatocellular; Cell Proliferation; Deoxyglucose; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Glucose; Glycolysis; GTP Phosphohydrolases; Humans; Liver Neoplasms; Mitochondria; Mitochondrial Dynamics; Mitochondrial Membrane Transport Proteins; Neoplasm Metastasis; Oxidative Phosphorylation; Reactive Oxygen Species; Signal Transduction | 2020 |
Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Cell Culture Techniques; Cell Line, Tumor; Coculture Techniques; Deoxyglucose; Drug Resistance, Neoplasm; Drug Synergism; Humans; Immune Checkpoint Inhibitors; Interferon-gamma; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Nanoparticle Drug Delivery System; Polylactic Acid-Polyglycolic Acid Copolymer; Tumor Escape; Warburg Effect, Oncologic; Xenograft Model Antitumor Assays | 2021 |
Oxidative phosphorylation activation is an important characteristic of DOX resistance in hepatocellular carcinoma cells.
Topics: Adenosine Triphosphate; ATP Synthetase Complexes; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Deoxyglucose; Doxorubicin; Drug Resistance, Neoplasm; Energy Metabolism; Glycolysis; Humans; Ketone Oxidoreductases; Liver Neoplasms; Malates; Methotrexate; Oxidative Phosphorylation | 2018 |
Omental splenosis after liver transplantation for hepatocellular carcinoma mimicking metastasis on fluoro-18-deoxyglucose positron emission tomography with computed tomography.
Topics: Carcinoma, Hepatocellular; Deoxyglucose; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Metastasis; Omentum; Positron-Emission Tomography; Splenosis; Tomography, X-Ray Computed | 2019 |
Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Cells, Cultured; Cyclic N-Oxides; Deoxyglucose; Drug Synergism; Enzyme Inhibitors; Glycolysis; Hep G2 Cells; Humans; Kinetics; Liver; Liver Neoplasms; Mitochondria, Liver; Molecular Targeted Therapy; Neoplasm Proteins; Organophosphorus Compounds | 2013 |
Two α-dicarbonyls downregulate migration, invasion, and adhesion of liver cancer cells in a p53-dependent manner.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Deoxyglucose; Down-Regulation; Drug Therapy, Combination; Genes, p53; Humans; Liver Neoplasms; Neoplasm Invasiveness; Pyruvaldehyde | 2013 |
Identification and Optimization of Combinatorial Glucose Metabolism Inhibitors in Hepatocellular Carcinomas.
Topics: 4-Chloro-7-nitrobenzofurazan; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Fluorescent Dyes; Glucose; Glucose Transporter Type 1; Humans; Liver Neoplasms; Precision Medicine | 2015 |
Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Drug Synergism; Female; G1 Phase Cell Cycle Checkpoints; Glucokinase; Glycolysis; HeLa Cells; Hep G2 Cells; Hexokinase; Humans; Lactic Acid; Liver Neoplasms; Membrane Potential, Mitochondrial; Mice; Neoplasm Transplantation; Triterpenes; Ursolic Acid | 2014 |
Sorafenib and 2-Deoxyglucose Synergistically Inhibit Proliferation of Both Sorafenib-Sensitive and -Resistant HCC Cells by Inhibiting ATP Production.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Drug Synergism; G1 Phase; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Resting Phase, Cell Cycle; Sorafenib | 2017 |
Golgi apparatus dis- and reorganizations studied with the aid of 2-deoxy-D-glucose and visualized by 3D-electron tomography.
Topics: Carcinoma, Hepatocellular; Deoxyglucose; Electron Microscope Tomography; Golgi Apparatus; Hep G2 Cells; Humans; Tumor Cells, Cultured | 2017 |
SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cell Survival; Cellular Structures; Cisplatin; Deoxyglucose; Drug Resistance, Neoplasm; Electron Spin Resonance Spectroscopy; Flow Cytometry; Fluorescent Antibody Technique; Humans; Immunoblotting; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Oxygen Consumption; RNA, Small Interfering; Sirtuin 1; Sirtuins; Tumor Cells, Cultured | 2008 |
PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline.
Topics: Acetates; Animals; Carbon; Carcinoma, Hepatocellular; Choline; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Marmota; Oligonucleotide Array Sequence Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Staining and Labeling; Tomography, X-Ray Computed | 2009 |
Enhancement of cytotoxic and pro-apoptotic effects of 2-aminophenoxazine-3-one on the rat hepatocellular carcinoma cell line dRLh-84, the human hepatocellular carcinoma cell line HepG2, and the rat normal hepatocellular cell line R
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Line; Cell Survival; Deoxyglucose; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Membrane Potential, Mitochondrial; Oxazines; Rats | 2012 |
[REACTIVE PROPERTIES OF 2-DESOXY-D-GLUCOSE-6PHOSPHATE IN HEPATOMAS AND EHRLICH-ASCITES CANCER CELLS].
Topics: Adenosine Triphosphate; Animals; Ascites; Carcinoma; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Deoxyglucose; Glucose; Glucosephosphate Dehydrogenase; Liver Neoplasms; Metabolism; NADP; Neoplasms, Experimental; Rats; Research | 1964 |
ON THE MECHANISM OF ACTION 2-DEOXYGLUCOSE UPON TUMOUR CELLS.
Topics: Acetates; Adenosine Triphosphate; Animals; Carcinoma; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Deoxyglucose; Glucose; Glycolysis; Liver Neoplasms; Metabolism; Mitochondria; Neoplasms, Experimental; Pharmacology; Research | 1964 |
Glucose depletion enhances P-glycoprotein expression in hepatoma cells: role of endoplasmic reticulum stress response.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Line, Tumor; Deoxyglucose; Drug Resistance, Multiple; Endoplasmic Reticulum; Glucose; Glycosylation; Humans; Liver Neoplasms; NF-kappa B; Oxidative Stress; Peptide Fragments; Proto-Oncogene Proteins c-jun; RNA, Messenger; Transcription Factor AP-1; Transcriptional Activation | 2003 |
Compartmentalization of transport and phosphorylation of glucose in a hepatoma cell line.
Topics: 3-O-Methylglucose; Animals; Biological Transport, Active; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Compartmentation; Cell Extracts; Cell Line, Tumor; Deoxyglucose; Dogs; Glucose; Glucose-6-Phosphatase; Hexokinase; Liver Extracts; Liver Neoplasms, Experimental; Monosaccharide Transport Proteins; Phosphorylation; Rats | 2005 |
2-[(3-carboxy-1-oxoprogy1) amino]-2-deoxy-D-glucose induces apoptosis in Hep G2 cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Flow Cytometry; Humans; Liver Neoplasms; Microscopy, Electron, Transmission | 2005 |
Effects of {2-[(3-carboxy-1-oxoprogy1)amino]-2-deoxy-D-glucose} on human hepatocellular carcinoma cell line.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Dose-Response Relationship, Drug; Humans; Liver Neoplasms; Microscopy, Electron, Transmission | 2005 |
Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line, HepG2.
Topics: Blotting, Northern; Carcinoma, Hepatocellular; Cell Line, Tumor; Dehydroepiandrosterone; Deoxyglucose; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gluconeogenesis; Glucose; Glucose-6-Phosphatase; Glucose-6-Phosphate; Humans; Liver Neoplasms; Protein Serine-Threonine Kinases; RNA, Messenger | 2005 |
O-[18F]fluoromethyl-L-tyrosine is a potential tracer for monitoring tumour response to chemotherapy using PET: an initial comparative in vivo study with deoxyglucose and thymidine.
Topics: Animals; Antibiotics, Antineoplastic; Carbon Radioisotopes; Carcinoma, Hepatocellular; Cell Line, Tumor; Deoxyglucose; Feasibility Studies; Liver Neoplasms, Experimental; Male; Mitomycin; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rats; Thymidine; Treatment Outcome; Tritium | 2006 |
Influence of an anti-diabetic foot ulcer formula and its component herbs on tissue and systemic glucose homeostasis.
Topics: 3T3 Cells; Adipocytes; Animals; Blood Glucose; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; Cells, Cultured; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Foot; Female; Fibroblasts; Glucose; Glucose Tolerance Test; Homeostasis; Humans; Mice; Microvilli; Phytotherapy; Plants, Medicinal; Rabbits; Rats; Rats, Wistar | 2007 |
Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose.
Topics: Adenosine Triphosphate; Antimetabolites; Apoptosis; Carcinoma, Hepatocellular; Cell Hypoxia; Deoxyglucose; Drug Resistance, Neoplasm; Glucose-6-Phosphate Isomerase; Glycolysis; HeLa Cells; Hexokinase; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Lactic Acid; Liver Neoplasms; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection | 2007 |
In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
Topics: Carcinoma, Hepatocellular; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Glucose-6-Phosphatase; Hexokinase; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Tomography, Emission-Computed | 1995 |
Insulin-like growth factor binding protein-1 from Hep G2 cells is potently inhibited by the truncated IGF-I analogue des-(1-3) IGF-I.
Topics: Analysis of Variance; Blotting, Northern; Carcinoma, Hepatocellular; Carrier Proteins; Culture Media; Deoxyglucose; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Glucose; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Liver Neoplasms; Peptide Fragments; Phenolsulfonphthalein; Radioimmunoassay; RNA; Somatomedins; Time Factors; Tumor Cells, Cultured | 1993 |
[Usefulness of 99mTc-PMT SPECT and 18F-FDG PET in diagnosing orbital metastasis of hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Orbital Neoplasms; Organotechnetium Compounds; Predictive Value of Tests; Pyridoxal; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tryptophan | 1994 |
Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging.
Topics: Abdominal Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Hemangioma, Cavernous; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Pelvic Neoplasms; Tomography, Emission-Computed | 1993 |
Modulation of the asialoglycoprotein receptor in human hepatoma cells: effect of glucose.
Topics: Asialoglycoprotein Receptor; Asialoglycoproteins; Binding Sites; Carcinoma, Hepatocellular; Culture Media; Cyclic GMP; Cycloheximide; Deoxyglucose; Glucose; Humans; Ligands; Liver Neoplasms; Precipitin Tests; Pyruvates; Pyruvic Acid; Receptors, Cell Surface; Tumor Cells, Cultured; Up-Regulation | 1994 |
[PET studies with C-11 ethanol in intratumoral therapy of hepatocellular carcinomas].
Topics: Aged; Blood Glucose; Brain; Brain Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Deoxyglucose; Ethanol; Female; Fluorodeoxyglucose F18; Humans; Injections, Intralesional; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed | 1996 |
Insulin-mimetic agents vanadate and pervanadate stimulate glucose but inhibit amino acid uptake.
Topics: Amino Acids; Animals; beta-Alanine; Carcinoma, Hepatocellular; Cell Line; Cycloheximide; Deoxyglucose; Drug Combinations; Enzyme Inhibitors; Glucose; Hypoglycemic Agents; Insulin; Muscle, Skeletal; Ouabain; Protein Tyrosine Phosphatases; Rats; Vanadates | 1997 |
Cell cycle and growth stage-dependent changes in the transport of nucleosides, hypoxanthine, choline, and deoxyglucose in cultured Novikoff rat hepatoma cells.
Topics: Animals; Biological Transport; Carcinoma, Hepatocellular; Cell Division; Cells, Cultured; Choline; Demecolcine; Deoxyglucose; DNA; Glucose; Hydroxyurea; Hypoxanthines; Kinetics; Liver Neoplasms; Mitosis; Neoplasms, Experimental; Nucleosides; Rats; Receptors, Drug; RNA, Neoplasm; Spectrometry, Fluorescence; Thymidine; Time Factors; Tritium; Uridine | 1975 |
Cyclic AMP, membrane transport and cell division. I. Effects of various chemicals on cyclic AMP levels and rate of transport of neucleosides, hypoxanthine and deoxyglucose in several lines of cultured cells.
Topics: Animals; Biological Transport, Active; Bucladesine; Carcinoma, Hepatocellular; Cell Division; Cell Line; Cell Membrane; Cell Transformation, Neoplastic; Cells, Cultured; Cyclic AMP; Cytochalasin B; Deoxy Sugars; Deoxyglucose; Depression, Chemical; Dipyridamole; Glioma; Hypoxanthines; Isoproterenol; L Cells; Liver Neoplasms; Mice; Papaverine; Prostaglandins; Rats; Thymidine; Uridine | 1975 |
The specific release of sialytransferase activity by human hepatoma cell lines.
Topics: Carcinoma, Hepatocellular; Cell Line; Child, Preschool; Chromatography, Gel; Cycloheximide; Deoxyglucose; Galactosyltransferases; Humans; Liver; Liver Neoplasms; Molecular Weight; Sialyltransferases; Subcellular Fractions; Transferases | 1979 |
Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.
Topics: Adenoma, Bile Duct; Carcinoma, Hepatocellular; Deoxyglucose; Fluorodeoxyglucose F18; Hexokinase; Humans; Liver; Liver Neoplasms; Tomography, Emission-Computed | 1992 |
Pattern of 2-deoxy-2-[18F]-fluro-D-glucose accumulation in liver tumours: primary, metastatic and after chemotherapy.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Colonic Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Fluorouracil; Humans; Interleukin-2; Liver Neoplasms; Recombinant Proteins; Rectal Neoplasms; Tomography, Emission-Computed | 1992 |
Intracellular targeting of the insulin-regulatable glucose transporter (GLUT4) is isoform specific and independent of cell type.
Topics: Adipose Tissue; Animals; Biological Transport, Active; Blotting, Western; Carcinoma, Hepatocellular; Cell Line; Cell Membrane; Deoxyglucose; Fluorescent Antibody Technique; Genetic Vectors; Humans; Insulin; Liver Neoplasms; Mice; Microscopy, Electron; Monosaccharide Transport Proteins; Plasmids; Rats; Transfection | 1991 |
[Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma].
Topics: Carcinoma, Hepatocellular; Cell Differentiation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Predictive Value of Tests; Retrospective Studies; Tomography, Emission-Computed | 1991 |
[Diagnosis of liver tumors with 18F-FDG and 18F-FDGal using PET].
Topics: Carcinoma, Hepatocellular; Deoxyglucose; Fluorodeoxyglucose F18; Fucose; Humans; Liver Neoplasms; Tomography, Emission-Computed | 1991 |
Insulin action on activity and cell surface disposition of human HepG2 glucose transporters expressed in Chinese hamster ovary cells.
Topics: Animals; Base Sequence; Biological Transport; Carcinoma, Hepatocellular; Cell Line; Cell Membrane; Cloning, Molecular; Cricetinae; Deoxyglucose; DNA; Fibroblasts; Gene Expression; Genetic Vectors; Humans; Immune Sera; Immunoblotting; Insulin; Liver Neoplasms; Metallothionein; Molecular Sequence Data; Monosaccharide Transport Proteins; Transfection; Tumor Cells, Cultured | 1990 |
Insulin regulation of hexose transport in mouse 3T3-L1 cells expressing the human HepG2 glucose transporter.
Topics: Adipose Tissue; Animals; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line; Cell Membrane; Cloning, Molecular; Deoxyglucose; Humans; Insulin; Liver Neoplasms; Mice; Molecular Weight; Monosaccharide Transport Proteins; RNA, Messenger; Transfection; Zinc | 1990 |
Functional expression of the human HepG2 and rat adipocyte glucose transporters in Xenopus oocytes. Comparison of kinetic parameters.
Topics: Adipose Tissue; Animals; Blotting, Western; Carcinoma, Hepatocellular; Cell Line; Cell Membrane; Deoxyglucose; Female; Genes; Humans; Kinetics; Liver Neoplasms; Monosaccharide Transport Proteins; Multigene Family; Oocytes; Rats; RNA, Messenger; Tumor Cells, Cultured; Xenopus | 1989 |
Monokine regulation of glucose transporter mRNA in L6 myotubes.
Topics: Actins; Animals; Carcinoma, Hepatocellular; Cell Line; Cell Nucleus; Cells, Cultured; Deoxyglucose; Humans; Kinetics; Liver Neoplasms; Macrophages; Monokines; Monosaccharide Transport Proteins; Muscles; RNA, Messenger; Transcription, Genetic; Transfection; Tumor Necrosis Factor-alpha | 1989 |
Expression of the human erythrocyte glucose transporter in Escherichia coli.
Topics: Base Sequence; Carcinoma, Hepatocellular; Cloning, Molecular; Cytochalasin B; Deoxyglucose; Electrophoresis, Polyacrylamide Gel; Erythrocytes; Escherichia coli; Gene Expression Regulation; Glucose; Humans; Immunoassay; Liver Neoplasms; Mercuric Chloride; Molecular Sequence Data; Monosaccharide Transport Proteins; Plasmids; Tumor Cells, Cultured | 1988 |
Imaging of hepatoma with 18F-fluorodeoxyglucose.
Topics: Carcinoma, Hepatocellular; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Radioisotopes; Radionuclide Imaging | 1985 |
Inhibition of transport systems in cultured rat hepatoma cells by colcemid and ethanol.
Topics: Animals; Biological Transport, Active; Carcinoma, Hepatocellular; Cell Line; Choline; Colchicine; Deoxyglucose; Depression, Chemical; Ethanol; Hypoxanthines; Liver Neoplasms; Mitosis; Neoplasms, Experimental; Rats; Tritium; Uridine | 1974 |